15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English MITA / STING及其选择性剪接同种型MRP限制乙型肝炎病毒 ...
查看: 601|回复: 3
go

MITA / STING及其选择性剪接同种型MRP限制乙型肝炎病毒复制 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2017-1-21 15:42 |只看该作者 |倒序浏览 |打印
MITA / STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication

    Shuhui Liu,
    Kaitao Zhao,
    Xi Su,
    Lu Lu,
    He Zhao,
    Xianwen Zhang,
    Yun Wang,
    Chunchen Wu,
    Jizheng Chen,
    Yuan Zhou,
    Xue Hu,
    Yanyi Wang,
    Mengji Lu,
    Xinwen Chen,
    Rongjuan Pei

PLOS

    Published: January 5, 2017
    Http://dx.doi.org/10.1371/journal.pone.016970

About the Authors

Shuhui Liu
    Affiliations State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China

Kaitao Zhao
    Affiliations State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China

Xi Su
    Affiliations State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China

Lu Lu
    Current address: Jiangdong Center for Disease Control and Prevention, Ningbo, China

    Affiliation Department of Microbiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

He Zhao
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Xianwen Zhang
    Affiliations State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China

Yun Wang
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Chunchen Wu
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Jizheng Chen
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Yuan Zhou
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Xue Hu
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Yanyi Wang
    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Mengji Lu
    Affiliation Institute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany

Xinwen Chen
    * E-mail: [email protected] (RP); [email protected] (XC)

    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

Rongjuan Pei
    * E-mail: [email protected] (RP); [email protected] (XC)

    Affiliation State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China

   
Abstract

An efficient clearance of hepatitis B virus (HBV) requires the coordinated work of both the innate and adaptive immune responses. MITA/STING, an adapter protein of the innate immune signaling pathways, plays a key role in regulating innate and adaptive immune responses to DNA virus infection. Previously, we identified an alternatively spliced isoform of MITA/STING, called MITA-related protein (MRP), and found that MRP could specifically block MITA-mediated interferon (IFN) induction while retaining the ability to activate NF-κB. Here, we asked whether MITA/STING and MRP were able to control the HBV replication. Both MITA/STING and MRP significantly inhibited HBV replication in vitro. MITA overexpression stimulated IRF3-IFN pathway; while MRP overexpression activated NF-κB pathway, suggesting these two isoforms may inhibit HBV replication through different ways. Using a hydrodynamic injection (HI) mouse model, we found that HBV replication was reduced following MITA/STING and MRP expression vectors in mice and was enhanced by the knockout of MITA/STING (MITA/STING-/-). The HBV specific humoral and CD8+ T cell responses were impaired in MITA/STING deficient mice, suggesting the participation of MITA/STING in the initiation of host adaptive immune responses. In summary, our data suggest that MITA/STING and MRP contribute to HBV control via modulation of the innate and adaptive responses.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2017-1-21 15:43 |只看该作者
MITA / STING及其选择性剪接同种型MRP限制乙型肝炎病毒复制

刘书辉,
Kaitao Zhao,
西苏,
卢陆,
何赵,
张先文,
王云,
吴春成,
陈志成,
元周,
薛虎,
王洋怡,
Mengji Lu,
陈新文,
荣娟裴

PLOS

发布时间:2017年1月5日
Http://dx.doi.org/10.1371/journal.pone.016970

关于作者

刘柳辉
中国科学院武汉病毒研究所病毒学国家重点实验室,中国武汉,中国科学院大学,北京,中国

赵开涛
中国科学院武汉病毒研究所病毒学国家重点实验室,中国武汉,中国科学院大学,北京,中国

西苏
中国科学院武汉病毒研究所病毒学国家重点实验室,中国武汉,中国科学院大学,北京,中国

卢路
当前地址:江东省疾病预防控制中心,宁波

华中科技大学同济医学院微生物学系,武汉

何赵
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

张文文
中国科学院武汉病毒研究所病毒学国家重点实验室,中国武汉,中国科学院大学,北京,中国

王云
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

吴春成
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

陈志成
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

元周
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

薛虎
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

王洋怡
中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

孟吉路
埃森大学医院病毒学家,杜伊斯堡 - 埃森大学,埃森,德国

陈新文
*电子邮件:[email protected](RP); [email protected](XC)

中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

荣娟裴
*电子邮件:[email protected](RP); [email protected](XC)

中国科学院武汉病毒研究所病毒学国家重点实验室,武汉

   
摘要

有效清除乙型肝炎病毒(HBV)需要协同工作的先天和适应性免疫反应。 MITA / STING,先天免疫信号传导途径的衔接蛋白,在调节对DNA病毒感染的先天和适应性免疫应答中起关键作用。以前,我们确定MITA / STING,称为MITA相关蛋白(MRP)的备选剪接同种型,并发现MRP可以特异性阻止MITA介导的干扰素(IFN)诱导,同时保留激活NF-κB的能力。在这里,我们询问MITA / STING和MRP是否能够控制HBV复制。 MITA / STING和MRP均显着抑制体外HBV复制。 MITA过表达刺激IRF3-IFN途径;而MRP过表达激活NF-κB通路,表明这两种亚型可能通过不同的方式抑制HBV复制。使用水动力注射(HI)小鼠模型,我们发现HBV复制减少后MITA / STING和MRP表达载体在小鼠和通过敲除MITA / STING(MITA / STING - / - )增强。在MITA / STING缺陷小鼠中,HBV特异性体液和CD8 + T细胞应答受损,表明MITA / STING参与宿主适应性免疫应答的启动。总之,我们的数据表明MITA / STING和MRP通过调节先天和适应性反应有助于HBV的控制。

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

3
发表于 2017-1-21 15:44 |只看该作者
In conclusion, although the baseline of MITA/STING expression was low in hepatoma cells, the complement of MITA/STING by overexpression restricted HBV replication significantly, suggesting an important role of MITA/STING in HBV persistence. The spliced variant of MITA/STING, MRP also inhibits HBV replication in vitro and in vivo, via the activation of NF-κB pathway. Deficiency of MITA/STING weakened HBV specific humoral and CTL responses, and consequently enhanced HBV replication in MITA/STING-/- mice, which indicated indispensable role of MITA/STING in adaptive response initiation. Due to the important role of MITA/STING in linking the innate response to adaptive response, the agonists to MITA/STING have been explored as vaccine adjuvants and for tumor treatment. Similarly, the MITA/STING agonists probably could be used as adjuvants of therapeutic vaccination for chronic HBV infection.

总之,尽管MITA / STING表达的基线在肝癌细胞中低,但是通过过表达的MITA / STING的补体显着限制了HBV复制,这表明MITA / STING在HBV持久性中的重要作用。 MITA / STING,MRP的剪接变体还通过NF-κB途径的活化在体外和体内抑制HBV复制。 MITA / STING的缺乏削弱了HBV特异性体液和CTL应答,因此增强了MITA / STING /小鼠中的HBV复制,这表明MITA / STING在适应性应答起始中不可或缺的作用。 由于MITA / STING在将先天反应与适应性反应联系中的重要作用,MITA / STING的激动剂已被作为疫苗佐剂和用于肿瘤治疗。 类似地,MITA / STING激动剂可能用作慢性HBV感染的治疗性接种的佐剂。

http://journals.plos.org/plosone ... ournal.pone.0169701
已有 1 人评分现金 收起 理由
MP4 + 8

总评分: 现金 + 8   查看全部评分

Rank: 6Rank: 6

现金
309 元 
精华
帖子
295 
注册时间
2015-6-30 
最后登录
2020-5-31 
4
发表于 2017-1-24 18:12 |只看该作者
真希望三年内有特效药出现!得了这个病太难受了!
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-5-14 05:12 , Processed in 0.016233 second(s), 12 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.